153 related articles for article (PubMed ID: 14689469)
1. Subacute toxicities and toxicokinetics of DA-8159, a new phosphodiesterase type V inhibitor, after single and 4-week repeated oral administration in rats.
Shim HJ; Kim YC; Jang JM; Park KJ; Kim DH; Kang KK; Ahn BO; Kwon JW; Kim WB; Lee MG
Biopharm Drug Dispos; 2003 Dec; 24(9):409-18. PubMed ID: 14689469
[TBL] [Abstract][Full Text] [Related]
2. Subacute toxicity and toxicokinetics of CJ-10882, a type IV phosphodiesterase inhibitor, after 4-week repeated oral administration in dogs.
Han J; Shin HC; Kim JC; Kim B
Food Chem Toxicol; 2004 Mar; 42(3):373-80. PubMed ID: 14871579
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of DA-8159, a new erectogenic, administered at 10:00 h versus 22:00 h in rats.
Lee JH; Kim YC; Kwon JW; Kim WB; Lee MG
Int J Pharm; 2005 May; 296(1-2):94-102. PubMed ID: 15885460
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic changes of DA-8159, a new erectogenic, after intravenous and oral administration to rats with acute renal failure induced by uranyl nitrate.
Shim HJ; Kim YC; Kim EJ; Kim DG; Kwon JW; Kim WB; Lee MG
Biopharm Drug Dispos; 2004 Apr; 25(3):137-42. PubMed ID: 15083502
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic changes of DA-8159, a new erectogenic, and one of its metabolites, DA-8164 after intravenous and oral administration of DA-8159 to spontaneously hypertensive rats and DOCA-salt-induced hypertensive rats.
Kim YC; Shim HJ; Lee JH; Kim DS; Kwon JW; Kim WB; Lee I; Lee MG
Biopharm Drug Dispos; 2005 Oct; 26(7):309-20. PubMed ID: 16035131
[TBL] [Abstract][Full Text] [Related]
6. Subacute toxicities and toxicokinetics of a new erectogenic, DA-8159, after single and 4-week repeated oral administration in dogs.
Shim HJ; Lee EJ; Kim JH; Kim SH; Kwon JW; Kim WB; Cha SW; Lee MG
Biopharm Drug Dispos; 2001 Apr; 22(3):109-17. PubMed ID: 11745913
[TBL] [Abstract][Full Text] [Related]
7. Acute, subchronic and chronic safety studies with genistein in rats.
Michael McClain R; Wolz E; Davidovich A; Pfannkuch F; Edwards JA; Bausch J
Food Chem Toxicol; 2006 Jan; 44(1):56-80. PubMed ID: 16213646
[TBL] [Abstract][Full Text] [Related]
8. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic interaction between 5-[2-propyloxy-5-(1-methyl-2-pyrollidinylethylamidosulfonyl)phenyl]-1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo (4,3-d) pyrimidine-7-one (DA-8159) and nitroglycerin in rats.
Lee SJ; Bae SK; Kwon JW; You M; Lee DC; Lee MG
J Pharm Pharmacol; 2005 Nov; 57(11):1397-405. PubMed ID: 16259771
[TBL] [Abstract][Full Text] [Related]
10. General 4-week toxicity study with EMS in the rat.
Pfister T; Eichinger-Chapelon A
Toxicol Lett; 2009 Nov; 190(3):271-85. PubMed ID: 19442710
[TBL] [Abstract][Full Text] [Related]
11. Effects of bacterial lipopolysaccharide on the pharmacokinetics of DA-8159, a new erectogenic, in rats.
Lee JH; Kim YC; Kwon JW; Kim WB; Lee MG
Res Commun Mol Pathol Pharmacol; 2005; 117-118():179-87. PubMed ID: 18426088
[TBL] [Abstract][Full Text] [Related]
12. Preclinical toxicity of a geldanamycin analog, 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG), in rats and dogs: potential clinical relevance.
Glaze ER; Lambert AL; Smith AC; Page JG; Johnson WD; McCormick DL; Brown AP; Levine BS; Covey JM; Egorin MJ; Eiseman JL; Holleran JL; Sausville EA; Tomaszewski JE
Cancer Chemother Pharmacol; 2005 Dec; 56(6):637-47. PubMed ID: 15986212
[TBL] [Abstract][Full Text] [Related]
13. Species differences in the formation of DA-8164 after intravenous and/or oral administration of DA-8159, a new erectogenic, to mice, rats, rabbits, dogs and humans.
Shim HJ; Kim YC; Lee JH; Park KJ; Kwon JW; Kim WB; Lee MG
Biopharm Drug Dispos; 2005 May; 26(4):161-6. PubMed ID: 15803515
[TBL] [Abstract][Full Text] [Related]
14. 4-Week repeated intravenous dose toxicity study of a new camptothecin anticancer agent CKD-602 in dogs.
Kim JC; Shin DH; Park SH; Park SC; Kim YB; Kim HC; Cha SW; Cho KH; Kang BH; Chung MK
Food Chem Toxicol; 2005 May; 43(5):699-706. PubMed ID: 15778009
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of intravenous and oral DA-8159, a new erectogenic, in rats with protein-calorie malnutrition.
Shim HJ; Kim YC; Lee JH; Ahn BO; Kwon JW; Kim WB; Lee I; Lee MG
J Pharm Pharmacol; 2004 Dec; 56(12):1543-50. PubMed ID: 15563761
[TBL] [Abstract][Full Text] [Related]
16. Uterotrophic assay, Hershberger assay, and subacute oral toxicity study of 4,4'-butylidenebis(2-tert-butyl-5-methylphenol) and 3-(dibutylamino)phenol, based on the OECD draft protocols.
Yamasaki K; Miyata K; Shiraishi K; Muroi T; Higashihara N; Oshima H; Minobe Y
Arch Toxicol; 2008 May; 82(5):301-11. PubMed ID: 17924095
[TBL] [Abstract][Full Text] [Related]
17. Toxicity and toxicokinetics of metformin in rats.
Quaile MP; Melich DH; Jordan HL; Nold JB; Chism JP; Polli JW; Smith GA; Rhodes MC
Toxicol Appl Pharmacol; 2010 Mar; 243(3):340-7. PubMed ID: 20004680
[TBL] [Abstract][Full Text] [Related]
18. Subacute toxicity evaluation of a new camptothecin anticancer agent CKD-602 administered by intravenous injection to rats.
Kim JC; Shin DH; Kim SH; Kim JK; Park SC; Son WC; Lee HS; Suh JE; Kim CY; Ha CS; Chung MK
Regul Toxicol Pharmacol; 2004 Dec; 40(3):356-69. PubMed ID: 15546689
[TBL] [Abstract][Full Text] [Related]
19. Chronic administration of phosphodiesterase 5 inhibitor improves erectile and endothelial function in a rat model of diabetes.
Ahn GJ; Yu JY; Choi SM; Kang KK; Ahn BO; Kwon JW; Kang SK; Lee BC; Hwang WS
Int J Androl; 2005 Oct; 28(5):260-6. PubMed ID: 16128985
[TBL] [Abstract][Full Text] [Related]
20. Subchronic oral toxicity of ubiquinol in rats and dogs.
Kitano M; Watanabe D; Oda S; Kubo H; Kishida H; Fujii K; Kitahara M; Hosoe K
Int J Toxicol; 2008; 27(2):189-215. PubMed ID: 18404543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
